Editas Medicine Stock Annual Yield

EDIT Stock  USD 1.21  0.04  3.20%   
Editas Medicine fundamentals help investors to digest information that contributes to Editas Medicine's financial success or failures. It also enables traders to predict the movement of Editas Stock. The fundamental analysis module provides a way to measure Editas Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Editas Medicine stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Editas Medicine Company Annual Yield Analysis

Editas Medicine's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.

Yield

 = 

Income from Security

Current Share Price

More About Annual Yield | All Equity Analysis

Editas Annual Yield Driver Correlations

Understanding the fundamental principles of building solid financial models for Editas Medicine is extremely important. It helps to project a fair market value of Editas Stock properly, considering its historical fundamentals such as Annual Yield. Since Editas Medicine's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Editas Medicine's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Editas Medicine's interrelated accounts and indicators.
0.95-0.81-0.830.860.750.990.610.950.660.850.380.930.750.850.80.960.92-0.660.780.60.750.65
0.95-0.81-0.830.820.510.910.51.00.590.680.390.860.580.820.840.930.93-0.630.870.620.830.72
-0.81-0.810.57-0.7-0.52-0.84-0.81-0.8-0.87-0.66-0.09-0.73-0.58-0.52-0.49-0.76-0.680.45-0.53-0.63-0.41-0.34
-0.83-0.830.57-0.87-0.54-0.77-0.36-0.85-0.41-0.67-0.78-0.88-0.6-0.89-0.93-0.8-0.940.9-0.77-0.21-0.85-0.92
0.860.82-0.7-0.870.640.820.570.850.610.780.550.860.70.870.820.790.91-0.680.590.230.70.71
0.750.51-0.52-0.540.640.810.630.520.570.890.240.770.870.610.410.670.55-0.490.310.340.30.27
0.990.91-0.84-0.770.820.810.690.90.710.860.290.940.780.780.70.950.85-0.630.70.630.630.54
0.610.5-0.81-0.360.570.630.690.50.860.72-0.020.660.690.380.180.560.41-0.380.090.270.020.05
0.951.0-0.8-0.850.850.520.90.50.590.70.440.870.60.850.870.930.96-0.670.860.570.840.76
0.660.59-0.87-0.410.610.570.710.860.590.680.110.620.660.390.260.580.47-0.380.280.40.230.12
0.850.68-0.66-0.670.780.890.860.720.70.680.310.820.980.820.570.710.71-0.540.470.310.490.47
0.380.39-0.09-0.780.550.240.29-0.020.440.110.310.540.290.570.690.380.59-0.840.45-0.30.680.8
0.930.86-0.73-0.880.860.770.940.660.870.620.820.540.730.810.760.940.87-0.830.650.360.660.66
0.750.58-0.58-0.60.70.870.780.690.60.660.980.290.730.770.480.590.61-0.490.40.240.410.41
0.850.82-0.52-0.890.870.610.780.380.850.390.820.570.810.770.90.740.92-0.680.750.250.820.85
0.80.84-0.49-0.930.820.410.70.180.870.260.570.690.760.480.90.760.96-0.750.830.30.920.95
0.960.93-0.76-0.80.790.670.950.560.930.580.710.380.940.590.740.760.87-0.70.760.60.710.61
0.920.93-0.68-0.940.910.550.850.410.960.470.710.590.870.610.920.960.87-0.730.810.40.870.87
-0.66-0.630.450.9-0.68-0.49-0.63-0.38-0.67-0.38-0.54-0.84-0.83-0.49-0.68-0.75-0.7-0.73-0.59-0.06-0.66-0.78
0.780.87-0.53-0.770.590.310.70.090.860.280.470.450.650.40.750.830.760.81-0.590.610.930.8
0.60.62-0.63-0.210.230.340.630.270.570.40.31-0.30.360.240.250.30.60.4-0.060.610.340.1
0.750.83-0.41-0.850.70.30.630.020.840.230.490.680.660.410.820.920.710.87-0.660.930.340.91
0.650.72-0.34-0.920.710.270.540.050.760.120.470.80.660.410.850.950.610.87-0.780.80.10.91
Click cells to compare fundamentals
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Competition

In accordance with the recently published financial statements, Editas Medicine has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Editas Medicine Current Valuation Drivers

We derive many important indicators used in calculating different scores of Editas Medicine from analyzing Editas Medicine's financial statements. These drivers represent accounts that assess Editas Medicine's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Editas Medicine's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap1.5B4.1B1.8B609.1M769.5M1.0B
Enterprise Value1.3B4.0B1.6B511.5M682.4M921.9M

Editas Fundamentals

About Editas Medicine Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Editas Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Editas Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Editas Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Editas Stock Analysis

When running Editas Medicine's price analysis, check to measure Editas Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Editas Medicine is operating at the current time. Most of Editas Medicine's value examination focuses on studying past and present price action to predict the probability of Editas Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Editas Medicine's price. Additionally, you may evaluate how the addition of Editas Medicine to your portfolios can decrease your overall portfolio volatility.